BioScience Health Innovations, Inc.
BHIC
$4.13
-$0.05-1.20%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 750.90K | 1.57M | 1.13M | 1.76M | 1.23M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 750.90K | 1.57M | 1.13M | 1.76M | 1.23M |
| Cost of Revenue | 265.40K | 1.00M | 433.20K | 683.00K | 330.90K |
| Gross Profit | 485.60K | 571.90K | 698.20K | 1.07M | 896.10K |
| SG&A Expenses | 715.50K | 728.50K | 707.00K | 616.80K | 469.30K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 980.90K | 1.73M | 1.14M | 1.30M | 800.30K |
| Operating Income | -229.90K | -156.70K | -8.80K | 457.70K | 426.80K |
| Income Before Tax | -229.90K | -156.70K | -8.80K | 457.70K | 426.80K |
| Income Tax Expenses | -- | 77.00K | -- | -- | -- |
| Earnings from Continuing Operations | -229.90K | -233.60K | -8.80K | 457.70K | 426.80K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -229.90K | -233.60K | -8.80K | 457.70K | 426.80K |
| EBIT | -229.90K | -156.70K | -8.80K | 457.70K | 426.80K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.02 | -0.02 | 0.00 | 0.04 | 0.01 |
| Normalized Basic EPS | -0.01 | -0.01 | 0.00 | 0.03 | 0.01 |
| EPS Diluted | -0.02 | -0.02 | 0.00 | 0.04 | 0.01 |
| Normalized Diluted EPS | -0.01 | -0.01 | 0.00 | 0.03 | 0.01 |
| Average Basic Shares Outstanding | 11.38M | 10.98M | 10.98M | 10.98M | 43.92M |
| Average Diluted Shares Outstanding | 11.38M | 10.98M | 10.98M | 11.08M | 44.34M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |